Who owns KALARIS THERAPEUTICS INC COM?
- Ticker: KLRS
- CUSIP Number: 482929106
Tip: Access positions for across all investors
Analyze quarterly positions in Kalaris Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kalaris Therapeutics stock
Who bought or sold KALARIS THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Samsara BioCapital | 13M | $52M | -1% | Jun 2026 |
|
| Rtw Investments | 1.3M | $5.3M | 0% | Jun 2026 |
|
| Alyeska Investment Group | 573k | $2.3M | 0% | Jun 2026 |
|
| Siren | 436k | $1.8M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 399k | $1.6M | 56% | Jun 2026 |
|
| Ikarian Capital | 360k | $1.5M | 0% | Jun 2026 |
|
| UBS Group | 262k | $1.1M | 4139% | Jun 2026 |
|
| Renaissance Technologies | 149k | $608k | 126% | Jun 2026 |
|
| Marshall Wace | 139k | $567k | 105% | Jun 2026 |
|
| Geode Capital Management | 114k | $464k | 30% | Jun 2026 |
|
| ADAR1 Capital Management | 100k | $407k | 0% | Jun 2026 |
|
| Woodline Partners | 100k | $407k | 0% | Jun 2026 |
|
| Whi Trust | 98k | $397k | 0% | Jun 2026 |
|
| Raymond James Financial | 97k | $396k | -18% | Jun 2026 |
|
| Citadel Advisors | 96k | $390k | 100% | Jun 2026 |
|
| Boothbay Fund Management | 92k | $376k | 0% | Jun 2026 |
|
| Verdad Advisers | 80k | $327k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 66k | $269k | 80% | Jun 2026 |
|
| BlackRock | 54k | $222k | 51% | Jun 2026 |
|
| Belpointe Asset Management | 40k | $163k | 0% | Jun 2026 |
|
| Fortis Capital Advisors | 40k | $163k | 0% | Jun 2026 |
|
| Pale Fire Capital SE | 40k | $161k | 100% | Jun 2026 |
|
| Squarepoint Ops | 39k | $158k | -3% | Jun 2026 |
|
| Morgan Stanley | 38k | $230k | 37% | Mar 2026 |
|
| Bridgeway Capital Management | 33k | $132k | 44% | Jun 2026 |
|
| Stonepine Capital Management | 30k | $123k | 48% | Jun 2026 |
|
| Connor, Clark & Lunn Investment Management | 30k | $122k | 120% | Jun 2026 |
|
| Trexquant Investment | 30k | $121k | 100% | Jun 2026 |
|
| State Street Corporation | 27k | $153k | 4% | Mar 2026 |
|
| Northern Trust | 26k | $105k | 79% | Jun 2026 |
|
| Velan Capital Investment Management | 25k | $102k | 39% | Jun 2026 |
|
| Two Sigma Investments | 24k | $97k | -22% | Jun 2026 |
|
| WealthTrust Asset Management | 20k | $83k | 64% | Jun 2026 |
|
| Independent Advisor Alliance | 18k | $74k | 27% | Jun 2026 |
|
| Rbf Capital | 17k | $71k | 0% | Jun 2026 |
|
| Quadrature Capital | 17k | $67k | 100% | Jun 2026 |
|
| Goldman Sachs Group | 16k | $65k | -85% | Jun 2026 |
|
| Dimensional Fund Advisors | 16k | $65k | 100% | Jun 2026 |
|
| Susquehanna International | 14k | $58k | -73% | Jun 2026 |
|
| Hrt Financial | 14k | $55k | 18% | Jun 2026 |
|
| Nano Cap New Millennium Growth Fund | 13k | $51k | 212% | Jun 2026 |
|
| Virtu Financial | 11k | $44k | 100% | Jun 2026 |
|
| Sigma Planning | 10k | $41k | 100% | Jun 2026 |
|
| Citigroup | 8.7k | $50k | 100% | Mar 2026 |
|
| FMR | 7.8k | $32k | 0% | Jun 2026 |
|
| Tower Research Capital | 2.6k | $10k | 1742% | Jun 2026 |
|
| Steward Partners Investment Advisory | 2.2k | $9.0k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 725.00 | $3.0k | 0% | Jun 2026 |
|
| Barclays | 303.00 | $1.2k | -94% | Jun 2026 |
|
| Strengthening Families & Communities | 268.00 | $1.1k | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 52.00 | $211.998800 | -92% | Jun 2026 |
|
| Jpmorgan Chase & Co | 50.00 | $210.870000 | 100% | Jun 2026 |
|
| Parallel Advisors | 49.00 | $198.998800 | 0% | Jun 2026 |
|
| Harbour Investments | 13.00 | $52.999700 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 12.00 | $0 | -88% | Jun 2026 |
|
| Caitong International Asset Management | 7.00 | $28.000000 | 100% | Jun 2026 |
|
| SBI Securities | 5.00 | $20.000000 | 0% | Jun 2026 |
|
Who sold out of Kalaris Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Paradigm Biocapital Advisors | Mar 2026 | 700k | $4.0M |
| Propel Bio Management | Mar 2026 | 296k | $1.7M |
| Kalehua Capital Management | Mar 2026 | 136k | $782k |
| Simplify Asset Management | Mar 2026 | 87k | $504k |
| Millennium Management | Mar 2026 | 60k | $344k |
| 683 Capital Management | Mar 2026 | 45k | $260k |
| Qube Research & Technologies | Mar 2026 | 11k | $64k |
| Keel Point | Dec 2025 | 10k | $86k |
| Johnson Financial Group | Mar 2026 | 10k | $58k |
| Fortitude Family Office | Mar 2026 | 114.00 | $657.996600 |
| Federated Investors | Mar 2026 | 34.00 | $195.999800 |